Fate Therapeutics Inc
FATE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001434316
In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Fate Therapeutics Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 164 | 159 | −5 |
| Shares | 114.8M | 101.7M | −13.1M (−11.4%) |
| Value | $401.6M | $166.5M | −$235.1M (−58.5%) |
New holders (35)
Institutions that held Fate Therapeutics Inc at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (40)
Institutions that held Fate Therapeutics Inc at the end of Q3 2024 and filed for Q4 2024 without it.